Novo Nordisk Chief Scientific Officer: We expect at least five oral drug candidates to be in clinical development by the end of this year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.